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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.004IL-27 is a heterodimeric cytokine composed of the subunits p28 and Epstein-Barr virus induced gene (EBI)-3
and is known for its effects on T-cell function and differentiation. IL-27 signals through the widely
expressed IL-27 receptor (IL-27R), composed of the ligand-speciﬁc IL-27Ra chain and gp130. Engagement
of the IL-27R activates STAT1 signaling, induces the expression of the type 1 helper T-cell (Th1) cytokine,
interferon g, and suppresses the differentiation of Th2 and Th17 cells. This study investigates the role of IL-
27 signaling in respiratory syncytial virus (RSV) infection using IL-27Raedeﬁcient mice (IL-27rKO).
Analysis of lungs from RSV-infected IL-27rKO mice showed exacerbation of mucus secretion compared with
wild type, as well as enhanced expression of Muc5ac and Gob5 mRNA, markers of goblet cell metaplasia/
hyperplasia. When compared with wild-type mice, RSV-challenged IL-27rKO mice had enhanced expression
of Th17-associated cytokine IL-17a and an imbalance between Th1 and Th2 cytokine levels. Neutralization
of IL-17 in RSV-infected IL-27rKO mice resulted in a signiﬁcant decrease in the pulmonary mucus response
and inhibition of the Th2-associated cytokines. Interestingly, IL-17 blockage led to an increase in the
expression of IL-27 subunits p28 and EBI-3 in the lungs and lymph nodes of RSV-infected mice. Thus, IL-27
functions as a regulatory cytokine during RSV pathogenesis by suppressing the development of Th17 cells,
but it also appears to be regulated by IL-17 induced by the virus. (Am J Pathol 2014, 184: 1807e1818;
http://dx.doi.org/10.1016/j.ajpath.2014.02.004)Supported by NIH grants AI073876 (N.W.L.) and T32 AI007413
(D.E.d.A.N.).
Disclosures: Amgen, Inc., provided the IL-27rKO mice.IL-27, a member of the IL-6/IL-12 family of cytokines, is a
heterodimeric cytokine composed of Epstein-Barr virus
induced gene (EBI)-3 and p28 subunits. It signals through a
receptor composed of WSX-1 [IL-27 receptor (IL-27R) a], a
class I cytokine receptor with homology to the IL-12 recep-
tor, and gp130, the common receptor chain used by several
cytokines.1 IL-27 is produced by antigen presenting cells
(APCs), especially dendritic cells (DCs), and its receptor is
found inmemory, regulatory, and effector CD4þT cells.2,3 In
T cells, engagement of the IL-27R activates members of the
STAT family, predominantly STAT1 and STAT3,2,4,5 and
leads to the up-regulation of T-bet and IL-12 receptor b2
expression, supporting type 1 helper T-cell (Th1) responses.4
However, studies conducted with several infectious and
autoimmune inﬂammatory diseases have shown that,
although the role of IL-27 in developing Th1 responses may
be redundant,6,7 it exerts a regulatory function in the immunestigative Pathology.
.system, because IL-27Redeﬁcient mice (IL-27rKO) are
prone to dysregulated T-cell responses and immune patho-
logical features.8e11 Accordingly, IL-27 activation of
STAT1 and T-bet suppresses GATA3 and the development
of Th2 cells.4 A study with Trichuris muris showed that IL-
27rKO mice control larvae infestation much faster than wild-
type (WT) mice because of the augmentation in Th2 cell
differentiation.8 In addition, IL-27 not only suppressed Th2
development but also inhibited the production of IL-5 and IL-
13 by differentiated Th2 cells in a dose-dependent manner.12 In
experimental asthma, a disease directly associated with Th2
response, mice lacking IL-27R had exacerbation of pulmonary
lesions when compared with WT mice. Conversely, intranasal
de Almeida Nagata et aladministration of IL-27 inhibited signs of asthma severity,
including airway hyperresponsiveness (AHR), goblet cell hy-
perplasia, and airway eosinophil inﬁltration.12 IL-27 also in-
hibits IL-6, IL-23, RAR-related orphan receptor (ROR)-gt, and
Th17 differentiation.13 In a study of autoimmune encephalitis,
IL-27R-deﬁcient mice developed a hyperinﬂammatory phe-
notype with enhanced differentiation and inﬁltration of Th17
cells. IL-27 regulated the disease by suppressing the develop-
ment of Th17 cell differentiation driven by IL-6 and trans-
forming growth factor-b in an STAT1-dependent and an
interferon (IFN)-geindependent way.14
Respiratory syncytial virus (RSV) infection leads to dif-
ferentiation of Th cells away from Th1 and toward Th2 and
Th17 subsets. Lung inﬂammation is a feature of RSV
infection, which is the single most important virus world-
wide, leading to respiratory tract infections during child-
hood.15 Severe RSV infection is associated with decreased
IFNg production, suggesting a Th1-type response is involved
in the viral clearance.16,17 Moreover, Th2 cytokines play
crucial roles in RSV-induced airway responses and lung
inﬂammation. IL-13 is known to induce goblet cell hyper-
plasia and mucus production,18 whereas IL-5edependent
eosinophilia has been implicated in RSV-induced AHR.19
Our laboratory showed that IL-17 participates in the patho-
genesis of RSV-induced disease.20 Mice inoculated with
RSV were found to display signiﬁcant up-regulation of IL-17
in the lungs and peribronchial lymph nodes (LNs). In addi-
tion, there was an increase in the transcript levels of IL-6 and
IL-23p19, which are involved in the differentiation and
maintenance of Th17 cells. Furthermore, IL-17 was shown to
up-regulate mucus production and to inhibit CD8þ T-cell
effector functions, thereby reducing viral clearance.
Because of the role that IL-27 plays in the Th phenotype
and in cell balance, we investigated its effects on RSV path-
ogenesis in IL-27rKO mice. We found that IL-27rKO mice
showed exacerbation of RSV-induced disease, including
mucus secretion, enhanced expression of the Th17-related
cytokine IL-17a and Th2-related cytokines IL-5 and IL-13,
and inhibition of the Th1-associated cytokine IFNg.
Neutralization of IL-17 in the RSV-infected IL-27rKO mice
resulted in a signiﬁcant decrease in the pulmonary mucogenic
response and inhibition of the Th2 cytokines IL-5, IL-4, and
IL-13. Moreover, IL-17 blockage led to a signiﬁcant increase
in the transcripts of IL-27 subunits p28 and EBI-3 in the lungs
and peribronchial LNs of RSV-infected mice. Thus, IL-27
functions not only as a regulatory cytokine during RSV
pathogenesis by suppressing the development of Th17 cells
but also appears to be regulated by the high levels of IL-17
induced by the virus.
Materials and Methods
Animals
The WT C57BL/6 controls were purchased from Taconic
Farms (Germantown, NY). IL-27ra knockout mice1808(IL-27rKO) were kindly provided by Amgen Inc (Thou-
sand Oaks, CA) and bred in-house. All mice were housed at the
University Laboratory Animal Facility at the University of
Michigan Medical School (Ann Arbor, MI). All animal exper-
iments were conducted according to animal protocols approved
by The Animal Use Committee at the University of Michigan.
Respiratory Tract Syncytial Infection
The RSV strain 2-20, kindly provided by Dr. Martin Moore
(Emory University, Atlanta, GA), was originally isolated
from a severely ill RSV-infected infant21 and propagated in
our laboratory in HEp-2 cells (ATCC, Manassas, VA). Mice
were anesthetized, and the virus was administered intra-
tracheally at 1  105 plaque-forming units (PFUs)22 on
day 0. Lungs were harvested at 1, 2, 4, 6, 8, and 12 days
after infection (dpi) for the time course study. For all other
studies, lungs were harvested at the time speciﬁed.
Plaque Assay
Plaque assays were performed on RSV-infected lungs, as
previously described,20 at 3 days after infection. For the plaque
assay experiments,micewere infectedwith theRSVstrain line
19 A2,23 kindly provided by Dr. Martin Moore (Emory Uni-
versity). After 3 days, viral plaques were visualized using goat
anti-RSVpolyclonal antibody (Ab;Millipore, Temecula,CA).
Primary Cell Isolation and Stimulation
Peribronchial LNswere enzymatically digestedusing 1mg/mL
collagenaseA (Roche, Indianapolis, IN) and 25U/mLDNase I
(Sigma-Aldrich, St. Louis, MO) in RPMI 1640 medium with
10% fetal calf serum for 1 hour. LNs were broken down me-
chanicallyusing18-gaugeneedles.Cellswere passed through a
40-mm strainer, and cell numbers were quantiﬁed. A total of
5  105 LN cells per well were cultured in a 96-well plate in
complete RPMI 1640 medium (10% fetal calf serum, peni-
cillin/streptomycin, L-glutamine, nonessential amino acids,
Na-pyruvate, and 50 mmol/L b-mercaptoethanol) and
restimulated with RSV [for 48 hours; multiplicity of infection
(MOI)Z0.5] forRNA isolation and cytokinemeasurements in
the culture supernatant.
Lung tissue was processed via enzymatic and mechanical
digestion, as previously described. Different cell populations
were accessed by ﬂow cytometry using an FACSAria II cell
sorter (BD Biosciences).
Bone marrow was ﬂushed from femur and tibia bones.
Bone marrowederived dendritic cells (BMDCs) and bone
marrowederived macrophages (BMDMs) were grown as
described previously.24 BMDCs and BMDMs were infected
with RSV, 20 mg/mL polyinosinic/polycytidylic acid (poly
I:C), 1 mg/mL imiquimod, or 100 ng/mL lipopolysaccharide
(LPS) for 24 hours for RNA extraction and measurement
of protein in the culture supernatant. When speciﬁed, 0.25
mg/mL of recombinant IL-17 (rIL-17)was added to the culture.ajp.amjpathol.org - The American Journal of Pathology
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Mice were pretreated i.p. with 2.5 mg of puriﬁed polyclonal
anti-mouse IL-17 antibody 2 hours before RSV infection on
day 0 and then every other day until day 6.20 The control group
similarly received 2.5 mg of anti-mouse IgG antibody (cab).
mRNA Extraction, Reverse Transcription, and Real-Time
PCR
mRNA was isolated from LN cell cultures and lung tissues
using TRIzol reagent (Invitrogen, Carlsbad, CA), according
to the manufacturer’s instructions. RNA (1 mg per sample)
was reverse transcribed using murine leukemia virus RTase
(Invitrogen). Expression levels of IL-2, IL-4, IL-5, IL-6, IL-
13, IL-17a, IFN-g, Foxp3, IL-10, IL-23, IL-27p28, EBI-3,
Gata-3, T-bet, and ROR-gt (Applied Biosystems, Grand Is-
land, NY) were analyzed with TaqMan gene expression as-
says (Applied Biosystems) using the 7500 Real-Time PCR
System (Applied Biosystems). Primers for RSV protein F
(RSV-F) and RSV protein G (RSV-G) were custom-made.
Gene expression was normalized to glyceraldehyde-3-
phosphate dehydrogenase and expressed as fold change
over the gene expression in control mice.
Cytokine Assay
Cytokine levels of IL-4, IL-5, IL-13, IFN-g, IL-17, and IL-10
were determined from cell culture supernatants using a Bio-
Plex assay (Bio-Rad, Hercules, CA). IL-27p28 was analyzed
in culture supernatants using an enzyme-linked immuno-
sorbent assay kit (R&D Systems Inc., Minneapolis, MN).
Flow Cytometry
Lung cells were stained for ﬂow cytometry as previously
described.24 Brieﬂy, cells were FcR blocked and stained with
anti-CD11c (N418), anti-Ly6C (HK1.4), and anti-Ly6G
(1A8) from Biolegend (San Diego, CA); anti-CD11b (M1/
70), anti-CD103 (2E7), and anti-F4/80 (BM8) from eBio-
science (San Diego, CA); and anti-GR1 (RBB6-8C5), anti-
IL5ra (T21), anti-CD86 (GL-1), and antieMHC-II/I Ab
(AF6-120.1) from BD Biosciences (San Jose, CA). Macro-
phages were gated as autoﬂuorescentþCD11chiF4/80mid;
CD11bþDCs were deﬁned as low-autoﬂuorescent CD11chi
MHCIIþCD11bhiCD103 cells; CD103þDCs were deﬁned
as low-autoﬂuorescent CD11chiMHCIIþCD11bloCD103þ
cells. Inﬂammatory neutrophils were gated as low-
autoﬂuorescent CD11cloCD11bhiLy6CþLy6Gþ; eosino-
phils were analyzed as low-autoﬂuorescent CD11cloCD11bhi
Gr1þIL5ra cells.
For intracellular cytokine staining, LN cell suspensions
were restimulated for 6 hours in complete medium containing
0.5 mL/mL GolgiPlug, 0.5 mL/mL GolgiStop (BD Bio-
sciences), 0.5 ng/mL phorbol 12-myristate 13-acetate, and
500 ng/mL ionomycin. Subsequently, LN cells were ﬁrstThe American Journal of Pathology - ajp.amjpathol.orgstained for surface markers with anti-CD3 (17A2), anti-CD4
(RM4-5), and anti-CD8 Abs (16-10A1), all from eBio-
science or BD Biosciences. Cells were then ﬁxed/per-
meabilized (BD Biosciences Fix/Perm Kit) and labeled with
antieIFN-g Ab (XMG1.2), anti-IL5 (TRFK8), anti-IL13
(ebio13A), and anti-IL17a (ebio17b7) from eBioscience,
and anti-IL4 (11B11) from Biolegend.
Histological Characteristics
Lungs were perfused with 4% formaldehyde for ﬁxation and
embedded in parafﬁn using standard histological techniques.
Lung sections were stained with H&E for analysis of inﬂam-
matory cell inﬁltration and PAS to detect mucus production.
Cellular inﬁltration and goblet cell hyperplasia in the airway
and lung tissues were evaluated using light microscopy by an
independent blinded observer (N.W.L.). The lung sections
were scored using the following scoring system: 0, absent; 1,
minimal; 2, slight; 3, moderate; and 4, severe.
Statistical Analysis
Reported values are expressed as means  SEM. Data were
analyzed and graphs were generated using GraphPad Prism
software 6 (GraphPad Software Inc, San Diego, CA). Statis-
tical signiﬁcance was assessed by a two-tailed Student’s t-test
for single-group analysis or one-way analysis of variance,
followed by a StudentNewman-Keuls test as a post hoc test for
multiple comparisons. P < 0.05 was considered signiﬁcant.
Results
RSV Infection Induces Early But Transitory IL-27
Expression by DCs
Because IL-27 subunits are expressed predominately by
macrophages and DCs,1 studies were designed to determine
whether RSV induces IL-27 in myeloid cell populations.
BMDCs and BMDMs were infected with RSV, and IL-27
expression was assessed by quantitative RT-PCR (RT-
qPCR). The results showed that RSV modestly up-regulates
the expression of both subunits of IL-27 (p28 and EBI-3) in
BMDCs (Figure 1A), but not in BMDMs (Figure 1B), 24
hours after infection. This up-regulation was transitory
because 48 hours after stimulation, no difference in IL-27
expression was detected between RSV-infected and RSV-
noninfected cells (data not shown). In addition, because
multiple toll-like receptor (TLR) pathways contribute to the
generation of the anti-RSV response,25 the effect of TLR
signaling on the expression levels of IL-27 was examined.
BMDCs were cultured in the presence of TLR3/poly I:C,
TLR7/imiquimod, and TLR4/LPS26 stimulus, each for 4,
6, and 24 hours. The results demonstrated that the TLR3
ligand poly I:C up-regulated the IL-27p28 subunit in a
time-dependent manner (Figure 1C), whereas the expression
levels of the subunit EBI-3 were modestly up-regulated at1809
Figure 1 RSV infection induces an early, but
transitory, IL-27 expression by DCs. BMDCs (A) and
BMDMs (B) were infected with RSV (MOI Z 0.5) for 6
and 24 hours. Cells were isolated, mRNA was extracted,
and transcripts of IL-27 subunits p28 and EBI were
measured by RT-qPCR. BMDCs were stimulated with TLR
ligands (poly I:C, imiquimod, and LPS) or kept unsti-
mulated (control). At 4, 6, and 24 hours, cells were
harvested, mRNA was isolated, and expression of the
IL-27 subunits p28 (C) and EBI-3 (D) was measured by
RT-qPCR. E: Expression of IL-27p28 and EBI-3 in the
lungs at day 1 to day 12 after RSV infection. Data
represent three independent experiments and are
presented as means  SEM (nZ 4 to 5 per group). F:
CD11bþDCs and CD103þDCs were sorted, using a ﬂu-
orescently activated cell sorter, from lungs of naïve WT
mice and infected in vitro with RSV for 48 hours. mRNA
was extracted, and expression of the IL-27 subunits
p28 and EBI-3 was measured by RT-qPCR. Cells were
sorted from the lungs of 10 mice, and data are pre-
sented as means  SEM of triplicate wells. *P < 0.05,
**P < 0.01, and ***P < 0.001.
de Almeida Nagata et al6 hours (Figure 1D). In addition, BMDC stimulation by the
TLR7 ligand imiquimod or by the TLR4 ligand LPS
induced high expression of both IL-27 subunits p28 and
EBI-3 early after activation, followed by a decrease in the
expression levels over time (Figure 1, C and D) when
compared with the unstimulated cell control group. To
determine the effect of RSV on IL-27 production in vivo,
WT mice were infected with 1.6  105 PFU RSV and a
kinetic analysis of IL-27 mRNA in the lungs was per-
formed. The results revealed an increase in IL-27p28 and
EBI-3 expression at 2 dpi, followed by a rapid decrease at 4,
6, 8, and 12 dpi (Figure 1E). Moreover, we analyzed which
DC population was responsible for the production of IL-27
in the lungs using ﬂow cytometry. CD11cþCD11bþDCs
and CD11cþCD103þDCs were cell sorted from lungs of
naïve WT mice and either stimulated with RSV or left
unstimulated for 48 hours in vitro. After mRNA isolation,
RT-qPCR analysis showed that both CD11cþCD11bþ and
CD11cþCD103þ up-regulated EBI-3 expression on RSV
infection compared with unstimulated cells, whereas IL-
27p28 expression was found to be up-regulated only in
CD11bþDCs (Figure 1F). Thus, these results show that
RSV infection induces an early IL-27 response by DCs in
the lungs, most likely by CD11cþCD11bþDCs, and this
response deteriorates during the progression of the infection.
IL-27 Signaling Impairment Results in Exacerbation of
RSV-Related Lung Pathological Features
The importance of IL-27 has been investigated in several
infectious and noninfectious diseases,26 and recent studies1810suggest that it has an immunoregulatory function.7e10 To
determine the importance of IL-27 in the pathogenesis of
RSV infection, IL-27rKO and WT mice were infected with
RSV and the histopathological pulmonary changes were
assessed. At 8 dpi, PAS staining of lung sections from
RSV-infected IL-27rKO animals showed worse goblet cell
hyperplasia and exacerbation of mucus secretion in the
large airways compared with the WT animals (Figure 2, A
and B). These animals also showed enhanced expression
of the mucus-associated genes Muc5ac (Figure 2C) and
Gob5a (Figure 2D). Because virus persistence and clear-
ance are important aspects of RSV-associated pathological
features, we then investigated whether virus persistence
was contributing to the disease-associated pathological
exacerbation observed in IL-27rKO mice. A kinetic anal-
ysis of RSV-F and RSV-G mRNA in the lungs of IL-
27rKO mice at 2, 3, 6, and 8 dpi showed that 3 dpi was
the peak of viral titers (Supplemental Figure S1). Thus,
differences in viral persistence and clearance between
RSV-infected WT and IL-27rKO animals were examined
at 3 dpi. A signiﬁcant increase in the expression of RSV-F
was detected in the lungs of IL-27rKO when compared
with WT mice (Figure 2E). Although RSV-G was also
increased in the lungs of IL-27rKO mice, the difference
did not reach statistical signiﬁcance. To conﬁrm this
ﬁnding, we measured viral load by assessing PFUs from
lungs of RSV-infected IL-27rKO and WT mice. Results
showed that, at 3 dpi, IL-27rKO had higher viral titers
compared with WT mice (Figure 2F). Moreover, airway
inﬂammation was evaluated by measuring cell inﬁltration in
lung homogenates of RSV-infected mice at 8 dpi by ﬂowajp.amjpathol.org - The American Journal of Pathology
Figure 2 RSV-infected IL-27rKO mice show exacerbation of mucogenic responses, goblet cell hyperplasia, and pulmonary inﬂammation. A: PAS staining of
lung sections of naïve or RSV-infected WT or IL-27rKO mice at 8 dpi, analyzed by light microscopy. B: Bar graph demonstrating histological score of mucus
assessed in lung sections of RSV-infected WT and IL-27rKO mice. The expression levels of mucus-associated genes Muc5ac (C) and Gob5 (D) were determined by
RT-qPCR of whole lung homogenates at 2, 6, and 8 dpi. E: mRNA was extracted from whole lungs of RSV-infected WT and IL-27rKO mice at 3 dpi, and expression
levels of the RSV proteins F and G were quantiﬁed by RT-qPCR. F: Viral PFU per wet weight of lung were measured in RSV-infected WT and IL-27rKO at 3 dpi.
G: Inﬁltration of eosinophils (EOS), macrophages (MACS), CD11bþDCs, CD103þDCs, and neutrophils (NEUT) in the lungs of RSV-infected WT and IL-27rKO mice at
8 dpi was assessed by ﬂow cytometry. H: Same as in G, but cells were isolated from bronchoalveolar lavage. I: Inﬁltration of CD4þCD69þ and CD8þCD69þ T cells in
the lungs of RSV-infected WT and IL-27rKO mice at 8 dpi assessed by ﬂow cytometry. Data represent three independent experiments and are presented as
means  SEM (nZ 4 to 5 per group). *P < 0.05, **P < 0.01, and ***P < 0.001. Original magniﬁcations: 20 (A); 100 (insets, bottom panels, A).
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infected IL-27rKO mice exhibited signiﬁcantly more mac-
rophages and CD11cþCD11bþDCs (Figure 2G). When
analyzing the bronchoalveolar lavage from these mice, in
addition to CD11cþCD11bþDCs and macrophages, RSV-
infected IL-27rKO mice also had higher levels of
CD11cþCD103þDCs, eosinophils, and neutrophils
compared with WT mice (Figure 2H). When assessing theThe American Journal of Pathology - ajp.amjpathol.orginﬁltration of lymphocytic populations, the proportion of
activated (CD69þ) CD4þ and CD8þ T cells was signiﬁ-
cantly higher in lungs of RSV-infected IL-27rKO mice
compared with WT mice (Figure 2I). Thus, results suggest
that RSV infection in mice with IL-27r deﬁciency leads to
exacerbation of lung pathological characteristics and in-
crease in mucus production, virus persistency, and inﬂam-
matory inﬁltration.1811
Figure 3 IL-27 regulates IL-17 production during RSV infection. A: Lung cells were recovered by enzymatic digestion from RSV-infected WT and IL-27rKOmice
at 8 dpi, and the inﬁltration of Th17 (CD3þCD4þIL17þ) was determined by ﬂow cytometry. mRNA was extracted from the whole lungs of naïve and RSV-infected
WT and IL-27rKO at 6 and 8 dpi. B: Expression levels of IL-17a were assessed by RT-qPCR. Peribronchial LNs were harvested from RSV-infected WT and IL-27rKO
mice at 6 and 8 dpi. Single-cell suspensions were obtained via enzymatic digestion, and cells were restimulated in vitro with RSV (MOIZ 0.5) for 48 hours. C: IL-
17 cytokine production was determined by Luminex (Austin, TX) assay. Data represent three independent experiments and are presented as means SEM (nZ 5
to 6 per group). *P < 0.05, ***P < 0.001.
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Infection
Because of the key role of IL-17a in exacerbation of RSV
infection20,25,27,28 and the importance of IL-27 in regulating
Th17 cells by inhibiting IL-17a production in an STAT1-
dependent manner,14,29e31 we asked whether IL-27r deﬁ-
ciency would affect IL-17a production and the inﬁltration of
Th17 cells during RSV infection. By using ﬂow cytometry,
lungs from RSV-infected IL-27rKO mice at 8 dpi showed
higher inﬁltration of Th17 (CD4þIL17aþ) cells compared
with RSV-infected WT mice (Figure 3A). Also, mRNA
isolated from lung homogenates showed that RSV-infected
IL-27rKO mice had a signiﬁcant increase in the expression
levels of IL-17a when compared with WT mice (Figure 3B).
To further conﬁrm these ﬁndings, we measured IL-17a pro-
duction by peribronchial LN cells isolated from RSV-
infected IL-27rKO and WT mice restimulated in vitro with
RSV for 48 hours. Results showed that LN cells from RSV-
infected IL-27rKO mice at 6 dpi, when restimulated with
RSV, produce signiﬁcantly higher IL-17 compared with WT
mice (Figure 3C). Next, because a recent study showed that
IL-27 acts on Th17 cell development by inhibiting Th17
lineage-speciﬁc transcription factor ROR-gt,31 we assessed
its expression in the peribronchial LNs of RSV-infected IL-
27rKO and WT mice. Although not statistically signiﬁcant,
IL-27rKO mice tended to have higher expression levels of
ROR-gt (Supplemental Figure S2A). More important,
because IL-6 and IL-23 have been shown to induce Th17
development, they were assessed. We found that the expres-
sion levels of IL-6 tended to be higher in the LNs of IL-27rKO
mice compared with WT mice; however, the difference did not
reach statistical signiﬁcance. Also, no difference was found in
the expression levels of IL-23 (Supplemental Figure S2B).
Thus, IL-27r deﬁciency affects RSV-related IL-17 production
in an IL-6/IL-23eindependent manner, most likely by having
the effect of STAT1 stimulation by IL-27 counteracted with
the absence of the IL-27 signaling, which may contribute to
the exacerbated pulmonary pathological characteristics found
in IL-27rKO mice.1812IL-27 Regulates Th1 and Th2 Cell Balance in the Lungs
during RSV Infection
Previous studies demonstrated that IL-27 promotes Th1 and
inhibits Th2 cells, subsets shown to be important in the
pathogenesis of RSV infection.18,19 Thus, we asked whether
mRNA and protein levels of Th1- and Th2-associated cy-
tokines were altered in the lungs of RSV-infected IL-27rKO
mice. By using ﬂow cytometry, we found that lungs from
IL-27rKO mice had signiﬁcantly lower inﬁltration of
CD4þIFNgþ Th1 cells compared with WT (Figure 4A) at 8
dpi. Gene expression of IFNg was also signiﬁcantly
decreased in the lungs of IL-27rKO mice (Figure 4B)
compared with WT mice at 6 dpi. To further verify our
ﬁndings, we assessed the protein levels of IFNg, IL-4, IL-5,
and IL-13 in the peribronchial LNs of RSV-infected IL-
27rKO and WT mice. In contrast to the results with lungs,
LN cells from RSV-infected IL-27rKO mice showed no
signiﬁcant decrease in the production of IFNg compared
with WT mice (Figure 4C). However, we observed a sig-
niﬁcant increase in the production of IL-5 (Figure 4D) and
IL-13 (Figure 4E) by LN cells derived from RSV-infected
IL-27rKO compared with WT mice at 6 dpi. However, no
signiﬁcant change in IL-4 production was detected
(Figure 4F). Next, we assessed the expression of the Th1
and Th2 lineage-speciﬁc transcription factors, T-bet and
Gata-3, in the lungs of RSV-infected IL-27rKO and WT
mice (Supplemental Figure S2, C and D). Accordingly,
T-bet expression was decreased, a result that correlated with
the lower expression levels of IFNg found in the lungs of
RSV-infected IL-27rKO mice. No signiﬁcant difference in
Gata-3 expression was detected when comparing lungs from
IL-27rKO and WT mice infected with RSV (Supplemental
Figure S2D). Although IL-27 has been described to be
important in the regulation of regulatory T cells (Tregs),
production of IL-10,32 and expression of the Treg-speciﬁc
transcription factor Foxp3,33e35 no changes in the gene
expression of IL-10 (Supplemental Figure S3A) and Foxp3
(Supplemental Figure S3B) were observed in the lungs of
RSV-infected IL-27rKO compared with WT mice.ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Deﬁciency in IL-27 signaling alters Th1 and Th2 cytokines during RSV infection. A: Results of ﬂow cytometric determination of the inﬁltration of
Th1 (CD3þCD4þIFNgþ) in the lungs. B: mRNA was extracted from the whole lungs of naïve and RSV-infected WT and IL-27rKO at 6 and 8 dpi, and expression
levels of IFNg were detected by RT-qPCR. Peribronchial LN cells were isolated from RSV-infected WT and IL-27rKO mice at 6 and 8 dpi and restimulated in vitro
with RSV (MOI Z 0.5) for 48 hours. IFNg (C), IL-5 (D), IL-13 (E), and IL-4 (F) cytokine production was determined by Luminex assay. Data represent three
independent experiments and are presented as means  SEM (n Z 5 to 6 per group). *P < 0.05, **P < 0.01.
IL-27 Regulates RSV-Dependent IL-17Furthermore, no difference was seen when analyzing the
inﬁltration of CD4þCD25þFoxp3þ Treg cells in the lungs of
these mice by ﬂow cytometry (Supplemental Figure S3C).
Also, no change in IL-10 production was detected in super-
natants derived from peribronchial LN cells of RSV-infected
IL-27rKO and WT mice restimulated in vitro with RSV
(Supplemental Figure S3D). Thus, data demonstrate that
RSV infection in mice that are IL27r deﬁcient lead to an
imbalance between Th1 and Th2, favoring the production of
pathogenic Th2 cytokines IL-5 and IL-13 in the LNs and
inhibiting the anti-viral Th1-associated cytokine IFNg.
These factors likely contribute to the more severe lung
pathological features found in the IL-27rKO mice in a Treg
celleindependent way.
AntieIL-17 Increases IL-27 Response and Attenuates
Lung Pathological Features
Previous studies indicated that IL-17 could directly induce
mucus production from pulmonary epithelial cells.20,36
Given the high levels of IL-17 found in the LNs and
lungs of RSV-infected IL-27rKO mice, studies were
designed to determine whether IL-17 played a role in the
exacerbation of the RSV infection observed in IL-27rKO
mice. To address this issue, IL-17 was neutralized in vivo
using passive immunization of IL-27rKO mice with antie
IL-17 Ab or with control IgG (cab) during RSV infection.
Our results show that RSV-infected IL-27rKO mice that
received antieIL-17 had a signiﬁcant inhibition in the
expression levels of IL-17a in the lungs compared with mice
that received cab (Figure 5A). Lung sections from RSV-
infected cab or antieIL-17etreated IL-27rKO mice wereThe American Journal of Pathology - ajp.amjpathol.orgstained with PAS to assess goblet cell hyperplasia and
mucus production. Microscopic analysis of lung sections
showed that antieIL-17etreated IL-27rKO mice had less
goblet cell hyperplasia, mucus production, and inﬂamma-
tory cell inﬁltration compared with the cab treatment
(Figure 5B). In addition, lungs from RSV-infected antieIL-
17etreated IL-27rKO mice had signiﬁcantly decreased
mucus production, as assessed by the expression of the
mucus-associated genes Muc5ac and Gob5 when compared
with the cab-treated group (Figure 5C). No difference in
viral gene expression was observed on antieIL-17 treat-
ment. In addition, we found that the antieIL-17 treatment
signiﬁcantly reduced the inﬁltration of CD4þ and CD8þ
activated (CD69þ) T cells (Figure 5D), as well as CD11bþ
DCs, CD103þDCs, and neutrophils (Figure 5E) in the lungs
of RSV-infected IL-27rKO mice compared with cab-treated
mice. Interestingly, IL-13 mRNA transcripts were signiﬁ-
cantly lower when RSV-infected IL-27rKO mice were
treated with antieIL-17 (Figure 5F) compared with cab
treatment. Moreover, the cytokine proﬁle in the peribron-
chial LNs of these animals was examined by restimulating
single LN cell suspensions from cab- or antieIL-17etreated
RSV-infected IL-27rKO mice with RSV in vitro for
48 hours. Compared with the cab-treated group, antieIL-
17etreated IL-27rKO LN cells had signiﬁcantly lower
production of the Th2-associated cytokines IL-4, IL-5, and
IL-13 (Figure 5G). The production of IFNg was not
changed by the treatment with antieIL-17 (Figure 5G).
Furthermore, the lungs of antieIL-17etreated RSV-infected
IL-27rKO mice had signiﬁcantly higher expression levels
of the IL-27 subunits p28 and EBI-3 compared with
cab-treated mice (Figure 6A), suggesting that by1813
Figure 5 Neutralization of IL-17 attenuates lung pathological features in IL-27rKO mice. mRNA was extracted from lung homogenates of cab- or antieIL-
17etreated RSV-infected IL-27rKO mice at 8 dpi. A: Expression levels of the IL-17a were measured by RT-qPCR. B: PAS staining of lung sections of cab- or
antieIL-17etreated RSV-infected IL-27rKO mice at 8 dpi analyzed by light microscopy. C: Mucus-associated genes Muc5ac and Gob5 were measured by RT-
qPCR. Lung cells were recovered by enzymatic digestion from antieIL-17 or cab-treated, RSV-infected IL-27rKO mice at 8 dpi and the inﬁltration of activated
CD4þCD69þ and CD8þCD69þ T cells (D), and neutrophils (neutro), dendritic cells (DCs), macrophages (MACS), and eosinophils (EOS) were determined by ﬂow
cytometry (E). F: mRNA levels of the Th1- and Th2-associated cytokines in the lungs were assessed by RT-qPCR. G: Peribronchial LN cells from cab- or antieIL-
17etreated RSV-infected IL-27rKO mice at 8 dpi. Single-cell suspensions were obtained via enzymatic digestion, and cells were restimulated in vitro with RSV
(MOI Z 0.5) for 48 hours. IL-4, IL-5, IL-13, and IFNg production levels were determined by a Luminex assay. Data are presented as means  SEM of four
replicate wells (n Z 5 to 6 per group). *P < 0.05, **P < 0.01, and ***P < 0.001. Original magniﬁcations: 10 (B); 40 (B, insets).
de Almeida Nagata et alneutralizing IL-17, IL-27 production could be up-regulated.
To further investigate the effect of IL-17 on IL-27 produc-
tion, mRNA was extracted from LNs of cab- or antieIL-
17etreated RSV-infected IL-27rKO mice rechallenged
in vitro with RSV. Our data showed that both subunits of
IL-27 (EBI-3 and p28) were increased when IL-17 was
neutralized; however, the increase seen in IL-27p28 did not
reach statistical signiﬁcance. Next, to further characterize
the IL-17 regulation of IL-27 production by DCs during
RSV infection, BMDCs were infected with RSV for 4, 8,
and 24 hours in the presence or absence of rIL-17. Our data
showed that during RSV infection, the addition of rIL-17
inhibited the expression of both IL-27 p28 and EBI-3 by
BMDCs at 24 hours after stimulation (Figure 6C). In
addition, to verify which component of the anti-RSV
response was involved in the down-regulation of IL-27
production by BMDCs when activated with rIL-17, we
stimulated BMDCs with multiple TLR ligands. The results
showed that BMDCs stimulated with the TLR3 ligand poly
I:C, in the presence of IL-17, produced signiﬁcantly lower
levels of IL-27 (Figure 6D). No signiﬁcant differences were
seen when cells were stimulated with control, imiquimod, or
LPS (Figure 6D). Thus, these data suggest that during RSV
infection, in the absence of IL-27r signaling, an over-
activation of the IL-17 pathway occurs, leading to a more
robust production of IL-17, which augments Th2-related
cytokine secretion by peribronchial LNs and pulmonary
mucus production. In addition, results suggest that over-
production of IL-17, induced during RSV infection, inhibits
IL-27 production by DCs in a TLR3-speciﬁc manner,
contributing to exacerbated lung pathological features,1814which might explain the low and transitory levels of IL-27
produced during RSV infection.Discussion
The clearance of virus in the lungs depends on a balanced
Th cell response to promote minimal pulmonary damage.
However, RSV-speciﬁc T-cell responses can often result in
severe pulmonary inﬂammation, partially due to an altered
immune environment.37e39 Herein, we report that, even
though the induction of IL-27 production by RSV is tran-
sitory, IL-27 signaling plays an important role in controlling
the severity of RSV infection by suppressing Th17 cells and
altering the Th cell response in the lungs. Because IL-27 is
produced by APCs,40 we ﬁrst analyzed whether RSV would
induce IL-27 production by BMDCs and BMDMs. Our
studies demonstrated that RSV induces modest expression
levels of the IL-27 subunits p28 and EBI-3 by BMDCs, but
not by BMDMs, and was further conﬁrmed using a kinetic
analysis of the expression proﬁle of IL-27 p28 and EBI-3
subunits in the lungs of RSV-infected mice.
In addition, RSV-F protein binds and activates the LPS
receptor TLR4,41 the activation of the chemokines chemo-
kine ligand 5 and CXCL10 can be regulated by the RSV-
related activation of TLR3,22 and TLR7 appears to regulate
IL-17emediated responses.25 Likewise, this study indicated
that all TLR3, TLR4, and TLR7 agonists resulted in
increased expression of the IL-27 subunits EBI-3 and p28 by
BMDCs, whereas reports showed that stimulation of TLR2
and TLR7/8 had only modest effects.40ajp.amjpathol.org - The American Journal of Pathology
Figure 6 IL-17 potentially regulates IL-27 production by RSV-infected DCs. mRNA was extracted from lung homogenates of cab- or antieIL-17etreated
RSV-infected IL-27rKO mice at 8 dpi. A: Gene expression of IL-27 subunits p28 and EBI-3 was assessed by RT-qPCR. Peribronchial LN cells were harvested from
cab- or antieIL-17etreated RSV-infected IL-27rKO mice at 8 dpi and restimulated in vitro with RSV (MOIZ 0.5) for 48 hours. B: mRNA was extracted, and the
expression levels of IL-27 subunits p28 and EBI-3 were measured by RT-qPCR. BMDCs were stimulated with RSV in the presence or absence of rIL-17 for 4, 8,
and 24 hours. C: Cells were harvested at each time point, mRNA was extracted, and gene expression of IL-27 subunits p28 and EBI-3 was measured by RT-qPCR.
DMDCs were stimulated with the TLR ligands imiquimod (TLR7), poly I:C (TLR3), or LPS (TLR4), or kept unstimulated (NIL) in the presence or absence of rIL-17.
D: After 48 hours, supernatants were harvested and the production of IL-27p28 (pg/mL) was measured by an enzyme-linked immunosorbent assay. Data are
presented as means  SEM of triplicate wells and represent two independent experiments (n Z 5 to 6 per group). *P < 0.05, **P < 0.01.
IL-27 Regulates RSV-Dependent IL-17By sorting distinct populations of DCs (CD11cþCD11bþ
and CD11cþCD103þ) from the lungs of naïve WT mice and
infecting them with RSV in vitro, our data revealed that the
CD11bþDCs are the primary source of IL-27 during RSV
infection, conﬁrming a study in a model of imiquimod-
induced psoriasis, which showed colocalization of IL-27
in DCs.42 Our in vivo data also showed that at 8 dpi, IL-
27rKO mice have increased inﬁltration of DCs and macro-
phages in the lungs compared with WT mice, suggesting a
role of these cells in modulating the T-cell immunity against
RSV and perpetuating the inﬂammatory response in IL-
27rKO mice. Interestingly, a previous study reported a
role for IL-27 in the functional suppression of DCs and
macrophages.43 Thus, the increased inﬁltration of DCs and
macrophages observed in the lungs of IL-27rKO mice may
be accompanied by up-regulation of cytokine production
and expression of accessory molecules by them, which may
affect the T-cellemediated inﬂammation on RSV infection.
Accordingly, the studies performed herein veriﬁed that the
exacerbation of the inﬂammatory response observed in the
lungs of IL-27rKO was related to altered T-cell responses, as
indicated by more activated CD4þ and CD8þ T cells in RSV-
infected IL-27rKOmice compared withWTmice. Moreover,
it has been proposed that the regulatory role of IL-27 is the
result of its suppressive effect on IL-2, a cytokine known to
induce cell proliferation and activation.44,45 Although we did
not ﬁnd evidence of increased IL-2 production in RSV-
infected IL-27rKO mice during our study (data not shown),
it is possible that IL-2 was transiently expressed early during
RSV infection, thus contributing to the increased inﬁltration
of activated T cells in the lungs.
A key ﬁnding in these studies was the signiﬁcant in-
crease in production of IL-17 in the lungs and peribron-
chial LNs of RSV-infected IL-27rKO mice compared with
WT mice. Indeed, it has been shown that IL-27 is capable
of inhibiting the development of Th17 cells in vitro.30,46
Studies focusing on the role of IL-27 in the development
of Th17 cells using IL-27rKO mice chronically infected
with Toxoplasma gondii or immunized with myelin oligo-
dendrocyte glycoprotein peptide to induce experimentalThe American Journal of Pathology - ajp.amjpathol.orgautoimmune encephalomyelitis have revealed that IL-27 is a
natural antagonist of Th17 activity.14,29,31 In these studies, the
lack of IL-27 signaling resulted in more Th cells and increased
IL-17 production. In a study of RSV vaccine-enhanced dis-
ease, mice co-immunized with pcDNA3eIL-27 and a re-
combinant vaccine candidate (G1F/M2) did not develop
vaccine-enhanced inﬂammatory responses or pulmonary dis-
ease after RSV challenge because the IL-27 plasmid caused
suppression in both Th2 and Th17 responses.39 In addition,
treatment of mice with rIL-27 suppressed the development of
experimental autoimmune encephalomyelitis, and was associ-
ated with decreased inﬁltration of Th17 cells and IL-17 pro-
duction in the central nervous system.29 In agreement with
previous reports, the increase in Th17 cell inﬁltration found in
IL-27rKOmice infected with RSV was accompanied by worse
lung pathological features when compared with WT mice.
Because IL-27 activation signals through STAT12,14 and
RSV-infected STAT1KO mice have increased production of
IL-17,47 we speculate that the increased IL-17 production
found in the lungs and LNs of RSV-infected IL-27redeﬁcient
mice might be STAT1 dependent.
Exacerbation of RSV-related pathological features,
mucus secretion, and AHR are associated with the produc-
tion of the Th2-related cytokines, especially IL-13.48 We
demonstrated that IL-27redeﬁcient mice have exacerbated
mucus production and increased levels of mucus-associated
genes Muc5ac and Gob5. Correspondingly, peribronchial
LNs in IL-27rKO mice had increased production of the Th2
cytokines IL-5 and IL-13 compared with WT mice. In
agreementwith our results, a study using T.muris showed that
IL-27rKO mice have an augmentation in Th2 cell differenti-
ation with an increase in the production of Th2-associated
cytokines, exaggerated goblet cell hyperplasia, mastocy-
tosis, and early clearance of larvae burden in the intestinal
track.8 In experimental asthma, mice lacking IL-27r had
exacerbation of pulmonary lesions when compared with WT
mice, with increased goblet cell hyperplasia at the bronchiole
and enhanced expression ofMuc5ac.10Conversely, intranasal
administration of IL-27 inhibited signs of asthma severity,
including AHR, goblet cell hyperplasia, and airway1815
de Almeida Nagata et aleosinophilic inﬁltration.12 The mechanism by which IL-27
inhibits Th2 cells may be, in part, due to its capacity to acti-
vate STAT1 and inhibit Gata-3, a critical transcription factor
for Th2 development.4 Although the present study did not
detect a signiﬁcant increase of GATA3 in the IL-27rKOmice,
a signiﬁcant decrease in T-bet was observed relating to the
altered Th cell phenotype. These results are in agreement with
studies showing the importance of IL-27 in Th1 cell devel-
opment through activation of STAT1 and T-bet.4 In addition,
IL-27redeﬁcient mice infected with Leishmania major7 and
Listeria monocytogenes49 also showed impaired IFNg pro-
duction compared withWTmice. On the basis of our ﬁndings
and the role of IFNg in virus clearance,16,17 we suggest that
the lack of IL-27r during RSV infection and inhibition of
IFNg could favor viral propagation and persistency, as
demonstrated by the increase in RSV-F gene expression and
enhanced virus titers in the lungs.
To determine whether IL-17 was responsible for the
exacerbated RSV infection found in IL-27rKO mice,
blockage of IL-17 during RSV infection was performed,
which reduced the severity of disease in RSV-infected IL-
27rKO mice. The inﬁltration of activated CD4þCD69þ and
CD8þCD69þ T cells also was reduced, suggesting inhibi-
tion of the inﬂammatory response. Moreover, the number of
neutrophils in the lungs of RSV-infected antieIL-17e
treated IL-27rKO was decreased, in agreement with previ-
ous studies relating IL-17 overproduction with the induction
of CXC chemokines, increased neutrophilic inﬁltration,
and consequent exacerbation of tissue damage and mucus
production.50e52 These results further conﬁrm a previous
study showing that IL-17 alters the epithelial cell response
that controls mucus production.53 Also, peribronchial LNs
from antieIL-17 or cab-treated RSV-infected IL-27rKO
mice produced signiﬁcantly less IL-4, IL-5, and IL-13, in
agreement with previous reports showing that neutralization
or the absence of IL-17 alters Th2-associated cyto-
kines.13,20,54 Strikingly, by neutralizing IL-17 during RSV
infection,we found that IL-27p28andEBI-3 subset transcripts
were up-regulated, suggesting a regulatory role of IL-17 in the
production of IL-27. Because DCs express the IL-17 receptor
and are able to respond to IL-17,55 we further investigated the
effect of IL-17 on the expression of IL-27 by BMDCs infected
withRSV.Results conﬁrmed that, in rIL-17estimulatedRSV-
infected DCs, the expression levels of IL-27 p28 and EBI-3
subunits are both inhibited. In addition, by studying the ef-
fect of IL-17 on RSV-related activation of TLRs in BMDCs,
data showed that IL-17 inhibition of IL-27 production was
veriﬁed during activation of TLR3. Because IL-17 did not
inhibit other TLR-mediated IL-27 production, it may be that
the TIR-domaindcontaining adapter-inducing IFN-b adapter
pathway is speciﬁcally altered in the presence of IL-17, which
would further reduce IL-27 production. Inmacrophages, IFNg
and the TLR4 agonist LPS synergistically induce the IL-27
constituent gene p28, in an MyD88-, c-Rele, interferon reg-
ulatory factor 1e, and NF-kBedependent manner.56 To the
best of our knowledge, this is the ﬁrst report suggesting a1816suppressive role of IL-17 and TLR3 signaling cascade in
the production of IL-27. IL-17 has been shown to activate
NF-kB,57 and the proximal activation of NF-kB in the IL-
17RA signaling pathway has been related to TNF receptor
associated factor 6,58 an important adaptor protein in the TLR
signaling cascades; however, TRIF has been shown to be
unnecessary for IL-17emediated signaling.57 Themechanism
involved in the TLR3eIL-17 regulation of IL-27 needs to be
further investigated. Thus, results suggest that the RSV-
dependent IL-17 overproduction inhibits IL-27 p28 and
EBI-3 subunit expression by DCs, perhaps by a feedback in-
hibition of the IL-17eIL-17 receptor interaction. This could
explain the low and transitory IL-27 expression levels in the
lungs of RSV-infected mice.
In summary, the data presented herein demonstrate that
IL-27 functions as a regulatory cytokine during RSV path-
ogenesis primarily by controlling Th17 cell development,
Th2-related cytokines, mucus production, and lung patho-
logical features.Acknowledgments
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